Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$58.87 - $83.05 $856,323 - $1.21 Million
14,546 Added 1359.44%
15,616 $1.25 Million
Q4 2022

Feb 10, 2023

BUY
$48.76 - $77.67 $51,685 - $82,330
1,060 Added 10600.0%
1,070 $54,000
Q3 2022

Nov 14, 2022

BUY
$61.42 - $86.29 $614 - $862
10 New
10 $1,000
Q3 2020

Nov 13, 2020

SELL
$11.98 - $16.34 $1.87 Million - $2.56 Million
-156,400 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$10.34 - $15.51 $75,357 - $113,036
7,288 Added 4.89%
156,400 $2.24 Million
Q1 2020

May 13, 2020

SELL
$9.11 - $20.05 $36,175 - $79,618
-3,971 Reduced 2.59%
149,112 $1.9 Million
Q4 2019

Feb 07, 2020

BUY
$18.47 - $24.03 $304,145 - $395,702
16,467 Added 12.05%
153,083 $3.14 Million
Q3 2019

Nov 13, 2019

BUY
$21.01 - $28.94 $2,584 - $3,559
123 Added 0.09%
136,616 $3.42 Million
Q2 2019

Aug 12, 2019

BUY
$23.33 - $28.3 $6,509 - $7,895
279 Added 0.2%
136,493 $3.86 Million
Q1 2019

May 10, 2019

BUY
$14.93 - $25.1 $123,456 - $207,551
8,269 Added 6.46%
136,214 $3.34 Million
Q4 2018

Feb 14, 2019

SELL
$12.68 - $19.01 $1,965 - $2,946
-155 Reduced 0.12%
127,945 $2 Million
Q3 2018

Nov 09, 2018

BUY
$13.1 - $16.35 $26,200 - $32,700
2,000 Added 1.59%
128,100 $1.92 Million
Q2 2018

Aug 10, 2018

BUY
$13.65 - $18.7 $51,870 - $71,060
3,800 Added 3.11%
126,100 $1.84 Million
Q1 2018

May 14, 2018

BUY
$14.85 - $24.3 $170,463 - $278,939
11,479 Added 10.36%
122,300 $1.95 Million
Q4 2017

Feb 13, 2018

SELL
$17.4 - $23.4 $198,359 - $266,760
-11,400 Reduced 9.33%
110,821 $2.27 Million
Q3 2017

Nov 13, 2017

BUY
$15.5 - $19.15 $1.89 Million - $2.34 Million
122,221
122,221 $2.18 Million

Others Institutions Holding LNTH

About Lantheus Holdings, Inc.


  • Ticker LNTH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 68,741,904
  • Market Cap $5.63B
  • Description
  • Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...
More about LNTH
Track This Portfolio

Track Globeflex Capital L P Portfolio

Follow Globeflex Capital L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.